The state of North Dakota currently has 1 active clinical trials seeking participants for COPD research studies. These trials are conducted in various cities, including Fargo, Bismarck, Grand Forks and Minot.
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
The purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab Dose 1 and Dose 2 administered subcutaneously (SC) in adult participants with symptomatic COPD and history of ≥ 2 moderate or ≥ 1 severe exacerbation of COPD in the previous 12 months. Participants should be receiving optimised treatment with maintenance inhaled therapy (ICS/LABA/LAMA triple therapy, or dual therapy if triple is not considered appropriate) in stable doses throughout at least 3 months prior... Read More
Between 40 years and 130 years
Trial Updated:
Locations: Research Site, Fargo, North Dakota
Conditions: Chronic Obstructive Pulmonary Disease (COPD)